AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Siglimepol Tablet

Prescription Icon
Prescription Required

Marketer

Medipol Pharmaceuticals India Pvt Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Siglimepol Tablet

Duo-Med Tablet combines two medications to manage elevated blood glucose in individuals with type 2 diabetes. This helps prevent serious diabetic complications like kidney failure and vision loss, and may lessen the risk of heart attack or stroke. Duo-Med Tablet can be used alone or with other diabetes treatments, and works optimally with a balanced diet and regular physical activity. Dosage is tailored to your health status, blood sugar readings, and other medications. Taking it with food minimizes stomach upset. Consistent daily dosing at the same time maximizes effectiveness; discontinue only under your doctor's guidance. Adhering to your prescribed diet and exercise plan is crucial for diabetes control. Common side effects include diarrhea, nausea, vomiting, indigestion, headache, and throat irritation. Low blood sugar (hypoglycemia) is possible, especially with insulin or sulfonylurea use; learn to recognize and address this. This medication isn't for everyone. Inform your doctor of any history of kidney, liver, or heart disease, pancreatic issues, or heavy alcohol consumption before starting. Pregnant or breastfeeding individuals should consult their physician. Other medications may interact with Duo-Med Tablet; disclose all medications for safety. Limit alcohol intake as it can lower blood sugar. Your doctor will monitor kidney function and blood sugar levels throughout treatment.

Primary Ingredients of Siglimepol Tablet

No text provided to rephrase.

Uses of Siglimepol Tablet

Managing Type 2 Diabetes

Major Benefits of Siglimepol Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Siglimepol Tablet with a meal.

Common Side effects of Siglimepol Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Siglimepol Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Siglimepol Tablet with a meal.

How Siglimepol Tablet works:

Siglimepol Tablet combines sitagliptin and metformin to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and increases insulin sensitivity. This dual action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Siglimepol Tablet with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Siglimepol Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Siglimepol Tablet while breastfeeding is likely inadvisable. Preliminary human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Siglimepol Tablets cautiously, potentially requiring dosage modification. Consult a physician before use. Siglimepol Tablets are contraindicated in those with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverUNSAFE

Patients with liver conditions should likely refrain from using Siglimepol Tablets due to potential safety concerns. A physician's consultation is recommended.

What if you forget to take Siglimepol Tablet :

Should you forget to take a Siglimepol Tablet, ingest it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosage regimen. Avoid taking a double dose.

Facts to Know About Siglimepol Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Siglimepol Tablet

Siglimepol Tablet combines sitagliptin and metformin to treat type 2 diabetes mellitus in adults. It helps control blood sugar when used with diet and exercise. Metformin reduces liver glucose production and improves insulin sensitivity, while sitagliptin enhances insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged Siglimepol Tablet use can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia and neurological issues, including numbness and tingling in extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Siglimepol Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Siglimepol Tablets are contraindicated in patients with known hypersensitivity to any component or excipient. This medication should not be used by individuals with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Siglimepol Tablet with alcohol is unsafe and may raise your risk of lactic acidosis.
Store this medication in its original, tightly closed container as directed on the label. Dispose of any unused medication properly and keep it out of reach of children, pets, and others.
Sitagliptin/Metformin can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also called Metformin-associated lactic acidosis or MALA). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those consuming large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Siglimepol Tablet, a combination of sitagliptin and metformin, treats type 2 diabetes mellitus in adults. It helps control blood sugar when used with diet and exercise. Metformin reduces liver glucose production and improves insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Siglimepol Tablet may cause common side effects such as low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Siglimepol Tablets are contraindicated in patients with hypersensitivity to any ingredient. Avoid use in patients with severe renal or hepatic impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Siglimepol tablets and alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also called Metformin-associated lactic acidosis or MALA). This rare side effect necessitates caution in patients with kidney disease, older adults, or those consuming significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged Siglimepol Tablet use can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and urinary issues), and cognitive changes (including balance problems). To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Siglimepol Tablet combines sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. Siglimepol is not suitable for individuals under 18.
Siglimepol Tablet may cause common side effects such as hypoglycemia (low blood sugar), taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Siglimepol Tablets are contraindicated in patients with known allergies to any component or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Siglimepol tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). While rare, this risk is higher in patients with kidney disease, older adults, and heavy alcohol users. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged Siglimepol Tablet use can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may cause anemia, neurological issues like numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, supplemental vitamin B12 is recommended at least annually by some researchers.
Store this medication in its original, tightly closed container, as directed on the label. Dispose of any unused medication properly and keep it out of reach of children, pets, and others.
Siglimepol Tablet
421